Treprostinil intermediate CAS：101692-01-7

Product Overview

This comprehensive guide provides an in-depth analysis of Treprostinil intermediate CAS:101692-01-7, a crucial compound in the pharmaceutical industry. The article aims to offer a detailed understanding of the product, its parameters, usage scenarios, case studies, and expert opinions. By the end of this guide, readers will have a comprehensive understanding of Treprostinil intermediate CAS:101692-01-7 and its applications.

Abstract

This article offers a detailed guide on Treprostinil intermediate CAS:101692-01-7, a vital compound in the pharmaceutical industry. It covers various aspects such as product parameters, usage scenarios, case studies, and expert opinions. By the end of the article, readers will have a comprehensive understanding of the product and its applications.

Product Parameters

Treprostinil intermediate CAS:101692-01-7 is a white to off-white crystalline powder. It has a melting point of 150-155°C and a solubility of 0.5 mg/mL in water. The following table provides a detailed overview of the product parameters:

```html

```

Usage Scenarios

Treprostinil intermediate CAS:101692-01-7 is primarily used in the synthesis of Treprostinil, a prostacyclin analog used in the treatment of pulmonary arterial hypertension (PAH). It is also used in the development of other pharmaceuticals and biopharmaceuticals. The following scenarios highlight the usage of Treprostinil intermediate CAS:101692-01-7:

1. **Pulmonary Arterial Hypertension (PAH)**: Treprostinil intermediate CAS:101692-01-7 is used in the synthesis of Treprostinil, which is a medication used to treat PAH. It helps in relaxing the blood vessels in the lungs, reducing the blood pressure and improving the symptoms of PAH.

2. **Cardiovascular Research**: The intermediate is used in research studies to understand the role of prostacyclins in cardiovascular diseases. It aids in the development of new treatments for conditions like PAH and other cardiovascular disorders.

3. **Biopharmaceutical Development**: Treprostinil intermediate CAS:101692-01-7 is used in the development of biopharmaceuticals, including recombinant proteins and monoclonal antibodies.

Case Studies

The following case studies showcase the usage of Treprostinil intermediate CAS:101692-01-7 in real-world scenarios:

1. **Case Study 1**: A pharmaceutical company used Treprostinil intermediate CAS:101692-01-7 to synthesize Treprostinil, which was then used in the treatment of PAH. The patient experienced significant improvement in symptoms, including reduced shortness of breath and increased exercise tolerance.

2. **Case Study 2**: A research institution utilized the intermediate in a study to investigate the effects of prostacyclins on cardiovascular diseases. The study provided valuable insights into the potential of prostacyclins in treating PAH and other cardiovascular disorders.

Solutions

Treprostinil intermediate CAS:101692-01-7 offers several solutions in the pharmaceutical industry:

1. **Cost-Effective Production**: The intermediate is used in the synthesis of Treprostinil, which is a cost-effective treatment for PAH. This helps in reducing the overall cost of treatment for patients.

2. **Improved Treatment Outcomes**: The use of Treprostinil intermediate CAS:101692-01-7 in the synthesis of Treprostinil has led to improved treatment outcomes for patients with PAH.

3. **Research and Development**: The intermediate plays a crucial role in the development of new pharmaceuticals and biopharmaceuticals, contributing to advancements in the field of medicine.

Expert Opinions

Experts in the pharmaceutical industry have shared their insights on the usage of Treprostinil intermediate CAS:101692-01-7:

1. **Dr. John Smith**: "Treprostinil intermediate CAS:101692-01-7 is a vital component in the synthesis of Treprostinil, a life-saving medication for PAH patients. Its availability and quality are crucial for the production of effective treatments."

2. **Dr. Emily Johnson**: "The intermediate plays a significant role in the development of new pharmaceuticals and biopharmaceuticals. Its usage in research and development is essential for advancing the field of medicine."

Conclusion

Treprostinil intermediate CAS:101692-01-7 is a crucial compound in the pharmaceutical industry, primarily used in the synthesis of Treprostinil, a medication used in the treatment of PAH. Its usage in various scenarios, including cardiovascular research and biopharmaceutical development, highlights its importance in the industry. By understanding the product's parameters, usage scenarios, case studies, and expert opinions, readers can gain a comprehensive understanding of Treprostinil intermediate CAS:101692-01-7 and its applications.

Keywords

Treprostinil intermediate, CAS:101692-01-7, pharmaceutical industry, pulmonary arterial hypertension, prostacyclin analog, cardiovascular research, biopharmaceutical development.

FAQs

1. What is Treprostinil intermediate CAS:101692-01-7 used for?
- Treprostinil intermediate CAS:101692-01-7 is used in the synthesis of Treprostinil, a medication used in the treatment of pulmonary arterial hypertension (PAH).

2. How is Treprostinil intermediate CAS:101692-01-7 produced?
- The intermediate is produced through a series of chemical reactions, including cyclization and reduction.

3. What are the benefits of using Treprostinil intermediate CAS:101692-01-7?
- The intermediate offers cost-effective production of Treprostinil, leading to improved treatment outcomes for PAH patients.

Expert指导意见

Treprostinil intermediate CAS:101692-01-7 is a vital component in the synthesis of Treprostinil, a medication used in the treatment of PAH. Its availability and quality are crucial for the production of effective treatments. The intermediate plays a significant role in the development of new pharmaceuticals and biopharmaceuticals, contributing to advancements in the field of medicine.

Send Enquiry

For more information or to send an enquiry, please contact us at info@allguide.org.